On Tuesday, Compugen Ltd (NASDAQ: CGEN) opened higher 3.04% from the last session, before settling in for the closing price of $2.30. Price fluctuations for CGEN have ranged from $1.35 to $3.03 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 142.78% over the past five years. Company’s average yearly earnings per share was noted 66.67% at the time writing. With a float of $84.72 million, this company’s outstanding shares have now reached $89.54 million.
Let’s look at the performance matrix of the company that is accounted for 68 employees. In terms of profitability, gross margin is 84.53%, operating margin of 17.67%, and the pretax margin is 25.27%.
Compugen Ltd (CGEN) Insider and Institutional Ownership
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Compugen Ltd is 5.38%, while institutional ownership is 14.06%.
Compugen Ltd (CGEN) Latest Financial update
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.05 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 66.67% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will plunge by -3.82% during the next five years compared to 12.14% growth over the previous five years of trading.
Compugen Ltd (NASDAQ: CGEN) Trading Performance Indicators
Check out the current performance indicators for Compugen Ltd (CGEN). In the past quarter, the stock posted a quick ratio of 4.14. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 3.55.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is 0.02, a number that is poised to hit 0.03 in the next quarter and is forecasted to reach -0.18 in one year’s time.
Technical Analysis of Compugen Ltd (CGEN)
Compugen Ltd (NASDAQ: CGEN) saw its 5-day average volume 0.46 million, a negative change from its year-to-date volume of 1.04 million. As of the previous 9 days, the stock’s Stochastic %D was 44.95%. Additionally, its Average True Range was 0.15.
During the past 100 days, Compugen Ltd’s (CGEN) raw stochastic average was set at 85.71%, which indicates a significant increase from 72.58% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 51.84% in the past 14 days, which was lower than the 59.19% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $1.79, while its 200-day Moving Average is $1.84. Nevertheless, the first resistance level for the watch stands at $2.45 in the near term. At $2.53, the stock is likely to face the second major resistance level. The third major resistance level sits at $2.60. If the price goes on to break the first support level at $2.30, it is likely to go to the next support level at $2.23. The third support level lies at $2.15 if the price breaches the second support level.
Compugen Ltd (NASDAQ: CGEN) Key Stats
There are currently 89,237K shares outstanding in the company with a market cap of 212.20 million. Presently, the company’s annual sales total 33,460 K according to its annual income of -18,750 K. Last quarter, the company’s sales amounted to 17,130 K and its income totaled 1,280 K.
